Alzheimer’s patient, 90, says skiing and other activities keep him mentally sharp
Six years after his Alzheimer’s diagnosis, 90-year-old Zelik Bocknek (Zel) refuses to slow down — and he believes his active ...
New drug targets for Alzheimer's identified from cerebrospinal fluid
A multitude of genes have been linked to the development of Alzheimer's disease. Specifically how those genes might influence ...
STAT1d
Mild Alzheimer’s patients won’t save Cassava Sciences
As we count down toward the December readout of Cassava Sciences’ simufilam Phase 3 clinical trial in Alzheimer’s disease, it ...
Medical Xpress on MSN3d
Most effective way to communicate with Alzheimer's patients identified
Research involving the UAB reveals the most effective way to talk to people with Alzheimer's so that their emotional response ...
‘The Unicorn' at UNTHSC is a gamechanger, say Alzheimer's researchers
Researchers say 'the Unicorn,' their invention at the University of Texas Health Science Center, is a game-changer in the ...
Alzheimer’s caregivers need updated drug rules to give families more time and peace | Opinion
Fortunately, the FDA has approved antipsychotic treatments that help manage these destructive symptoms, and more are in ...
How Cannabis Is Changing Dementia Care For Patients And Families
Cannabis is emerging as a tool in dementia care, offering relief from anxiety and agitation when traditional medications fall ...
EU regulator backs Eisai-Biogen Alzheimer's drug after initial rejection
The European Union's drugs regulator on Thursday recommended approval of Eisai and Biogen's Leqembi for some patients with ...
'We are very hopeful' | New nasal spray could delay Alzheimer's by years, researchers say
Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling ...
STAT7h
Changing course, European regulators now say Alzheimer’s treatment Leqembi should be approved
Reversing an earlier decision, European regulators recommended that an Alzheimer’s therapy from Eisai and Biogen should be ...
DPA International on MSN3h
EU regulator reverses decision to block Alzheimer's drug lecanemab
The European Union's drugs regulator reversed its decision to block the Alzheimer's drug lecanemab, a treatment aimed at ...
Yahoo6d
Alzheimer’s patient, 90, says skiing and other activities keep him mentally sharp
Alzheimer’s Disease Could Be Slowed By Boosting A Certain Protein In The Brain, Researchers Say Beyond cognition, exercise also helps to improve patients’ physical health, including their ...